References
- Blair SN, Cheng Y, Holder JS. Is physical activity or physical fitness more important in defining health benefits? Med. Sci. Sports Exerc.33(6 Suppl.), S379–S399 (2001).
- Bedard S, Marcotte B, Marette A. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem. J.15(325), 487–493 (1997).
- Piepoli MF, Davos C, Francis DP, Coats AJ. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). Br. Med. J.328(7433), 189 (2004).
- Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA286(10), 1218–1227 (2001).
- Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol.58(3), 498–504 (2001).
- Larson EB, Wang L, Bowen JD et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med.144(2), 73–81 (2006).
- Podewils LJ, Guallar E, Kuller LH et al. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am. J. Epidemiol.161(7), 639–651 (2005).
- Winocour PH, Durrington PN, Bhatnagar D et al. A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus. Diabetes Res. Clin. Pract.18(3), 173–184 (1992).
- Pedersen BK, Steensberg A, Fischer C et al. Searching for the exercise factor – is IL-6 a candidate. J. Musc. Res. Cell Motility24(2–3), 113–119 (2003).
- Pedersen BK, Steensberg A, Fischer C et al. The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proc. Nutr. Soc.63(2), 263–267 (2004).
- Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration and adaption. Physiol. Rev.80, 1055–1081 (2000).
- Pedersen BK, Steensberg A, Schjerling P. Muscle-derived interleukin-6: possible biological effects. J. Physiol. (Lond.)536(Pt 2), 329–337 (2001).
- Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J.16(11), 1335–1347 (2002).
- Febbraio MA, Hiscock N, Sacchetti M, Fischer CP, Pedersen BK. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes53(7), 1643–1648 (2004).
- Nybo L, Moller K, Pedersen BK, Nielsen B, Secher NH. Association between fatigue and failure to preserve cerebral energy turnover during prolonged exercise. Acta Physiol. Scand.179(1), 67–74 (2003).
- Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans. FASEB J.17(8), 884–886 (2003).
- Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science271(5249), 665–668 (1996).
- Petersen EW, Pedersen BK. The anti-inflammatory effect of exercise. J. Appl. Physiol.98(4), 1154–1162 (2005).